• 1
    Sartor, R. B., Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994. 106: 533539.
  • 2
    Fiocchi, C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998. 115: 182205.
  • 3
    Blumberg, R. S., Saubermann, L. J. and Strober, W., Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 1999. 11: 648656.
  • 4
    Elson, C. O., Sartor, R. B., Tennyson, G. S. and Riddell, R. H., Experimental models of inflammatory bowel disease. Gastroenterology 1995. 109: 13441367.
  • 5
    Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993. 75: 263274.
  • 6
    Parronchi, P., Romagnani, P., Annunziato, F., Sampognaro, S., Becchio, A., Giannarini, L., Maggi, E., Pupilli, C., Tonelli, F. and Romagnani, S., Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 1997. 150: 823832.
  • 7
    Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K. and Tonegawa, S., Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993. 75: 274282.
  • 8
    Boirivant, M., Fuss, I. J., Chu, A. and Strober, W., Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 1998. 188: 19291939.
  • 9
    Dohi, T., Fujihashi, K., Rennert, P. D., Iwatani, K., Kiyono,H. and McGhee, J. R., Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J. Exp. Med. 1999. 189: 11691180.
  • 10
    Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C. and Strober, W., Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996. 157: 12611270.
  • 11
    Dubucquoi, S., Janin, A., Klein, O., Desreumaux, P., Quandalle, P., Cortot, A., Capron, M. and Colombel, J. F., Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995. 37: 242246.
  • 12
    Choy, M. Y., Walker-Smith, J. A., Williams, C. B. and MacDonald, T. T., Activated eosinophils in chronic inflammatory bowel disease. Lancet 1990. 336: 126127.
  • 13
    Weller, P. F., The immunobiology of eosinophils. N. Engl. J. Med. 1991. 324: 11101118.
  • 14
    Rothenberg, M. E., Mishra, A., Brandt, E. B. and Hogan, S. P., Gastrointestinal eosinophils. Immunol. Rev. 2001. 179: 139155.
  • 15
    Matsumoto, S., Okabe, Y., Setoyama, H., Takayama, K., Ohtsuka, J., Funahashi, H., Imaoka, A., Okada, Y. and Umesaki, Y., Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998. 43: 7178.
  • 16
    Kosiewicz, M. M., Nast, C. C., Krishnan, A., Rivera-Nieves, J., Moskaluk, C. A., Matsumoto, S., Kozaiwa, K. and Cominelli, F., Th1-type responses mediatespontaneous ileitis in a novel murine model of Crohn's disease. J. Clin. Invest. 2001. 107: 695702.
  • 17
    Bamias, G., Marini, M., Moskaluk, C. A., Odashima, M., Ross,W. G., Rivera-Nieves, J. and Cominelli, F., Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J. Immunol. 2002. 169: 53085314.
  • 18
    Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., Schaible, T. F. and van Deventer, S. J., Infliximab for the treatment of fistulas in patients with Crohn's disease. N. Engl. J. Med. 1999. 340: 13981405.
  • 19
    Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C. and Dayer, J. M., CCR5 is characteristic of Th1 lymphocytes. Nature 1998. 391: 344345.
  • 20
    Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E. and Charo, I. F., Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 1997. 100: 25522561.
  • 21
    Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A. and Sinigaglia, F., Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998. 187: 129134.
  • 22
    Zingoni, A., Soto, H., Hedrick, J. A., Stoppacciaro, A., Storlazzi, C. T., Sinigaglia, F., D'Ambrosio, D., O'Garra, A., Robinson, D., Rocchi, M., Santoni, A., Zlotnik, A. and Napolitano, M., The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 1998. 161: 547551.
  • 23
    Kita, H. and Gleich, G. J., Chemokines active on eosinophils: potential roles in allergic inflammation. J. Exp.Med. 1996. 183: 24212426.
  • 24
    Mishra, A., Hogan, S. P., Lee, J. J., Foster, P. S. and Rothenberg, M. E., Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J. Clin. Invest. 1999. 103: 17191727.
  • 25
    Tomaki, M., Zhao, L. L., Lundahl, J., Sjostrand, M., Jordana, M., Linden, A., O'Byrne, P. and Lotvall, J., Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J. Immunol. 2000. 165: 40404050.
  • 26
    Marini, M., Bamias, G., Rivera-Nieves, J., Moskaluk, C. A., Hoang, S. B., Ross, W. G., Pizarro, T. T. and Cominelli, F., TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. USA 2003. 100: 83668371.
  • 27
    Mizoguchi, E., Mizoguchi, A. and Bhan, A. K., Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice. Lab. Invest. 1997. 76: 385397.
  • 28
    Andres, P. G., Beck, P. L., Mizoguchi, E., Mizoguchi, A., Bhan, A. K., Dawson, T., Kuziel, W. A., Maeda, N., MacDermott, R. P., Podolsky, D. K. and Reinecker, H. C., Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodiumsulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 2000. 164: 63036312.